small cell lung cancer icd 9

... 2009 Radiation Oncology 2009, 4:68 doi:10.1186/1748-717X-4-68 Received: 12 October 2009 Accepted: 21 December 2009 This article is available from: http://www.ro-journal.com/content/4/1/68 © 2009 ... glands [8] Similar findings were made for non-small-cell lung cancer (NSCLC), where a continuous tumor regression during radiotherapy was observed [9] This continuous tumor regression during radiotherapy ... performance of surface-based deformable image registration (DR) for adaptive radiotherapy of non-small cell lung cancer (NSCLC) Methods: Based on 13 patients with locally advanced NSCLC, CT images acquired

Ngày tải lên: 09/08/2014, 10:20

... mito- mycin, vindesine, and cisplatin in unresectable stage III non- small-cell lung cancer. J Clin Oncol 1999, 17:2692-2699. 19. Martel MK, Ten Haken RK, Hazuka MB, Kessler ML, Strawderman M, Turrisi ... therapy evolved thus from a dose of 55 Gy split course in 1995 to 66 Gy continuously in 1997. Since 1997 we have participated in EORTC-08972/22973. In this trial sequential versus concurrent radio-chemo- ... doses of cisplatin in combination with accelerated radi- otherapy in non-small cell lung cancer. Eur J Cancer 1996, 32A:1314-1319. 7. Uitterhoeve AL, Belderbos JS, Koolen MG, van der Vaart P, Rodrigus

Ngày tải lên: 09/08/2014, 10:21

... 157,300 deaths from lung cancer [4]. Lung cancer has traditionally been dichotomized into two groups based on the histological features of the tumor: small cell and non-small cell lung cancer. NSCLC ... non-small cell lung cancer comprise the majority of cases annotated within the database. Other cancers contained in the database include small cell lung cancer, mesothelioma, esophageal cancer, ... SEER Cancer Statistics Review, 1975-2007. National Cancer Institute. Bethesda, MD; [http://seer.cancer.gov/csr/1975_2007]. 5. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA: Non-small cell lung

Ngày tải lên: 10/08/2014, 09:22

... levels in normal lung tissues, and nonsmall cell lung cancers. Jpn J Cancer Res 1999, 90:1338-43. 11. Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases ... Cancer 2000, 89(12):2637-45. 9. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Research 1998, 58(22):4997-5001. ... the lung. Lung Cancer 2000, 30:73-81. 4. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimäki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998, 58:4997-5001.

Ngày tải lên: 10/08/2014, 10:20

... A549, A549/miR-NC or A549/miR-451 cells B Hoechst staining analysis of apoptosis in mock A549, A549/miR-NC or A549/ miR-451 cells C Analysis of relative caspase-3 activity in mock A549, A549/miR-NC ... 2010, 9:2742-2748 doi:10.1186/1756-9966-30-20 Cite this article as: Bian et al.: Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549) Journal ... expression in mock A549, A549/miR-NC or A549/miR-451 cells GAPDH was used as an internal control B Analysis of relative caspase-3 activity in mock A549, A549/miR-NC or A549/miR-451 cells All experiments

Ngày tải lên: 10/08/2014, 10:21

... non small -cell lung cancer Clin Lung Cancer... subgroup analysis of tribute, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer Clin Cancer ... non-small cell lung cancer Clin Cancer Res 2006, 12:3078-3084 Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS: K-ras mutations in non-small- cell lung carcinoma: a review Clin Lung ... advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease Lung Cancer 2004, 44:99-110...

Ngày tải lên: 10/08/2014, 22:20

... several key studies in non-small-cell lung cancer (NSCLC) The purpose of this article is to review several important abstracts that were presented in different lung cancer tracts, which may influence ... and Chung T Hsueh Abstract We have reviewed the pivotal presentations in non-small cell lung cancer (NSCLC) from the 2009 annual meeting of the American Society of Clinical Oncology We have discussed ... http://www.jhoonline.org/content/3/1/18 JOURNAL OF HEMATOLOGY & ONCOLOGY Open Access REVIEW Updates in non-small cell lung cancer - insights from the 2009 45th annual meeting of the American Society of Clinical Oncology Review

Ngày tải lên: 10/08/2014, 22:21

... mechanism in an ovarian cancer cell line in vivo Cancer Res 1991, 51:5956-5959 Jordan JD, Landau EM, Iyengar R: Signaling networks: the origins of cellular multitasking Cell 2000, 103:193-200 Di Ventura ... Modelling 2007, 4:50 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 metastatic variant of a human non-small-cell lung cancer cell line Br J Cancer 1996, 74:1776-1782 Kurachi H, Morishige ... + X19/K18) + X18] V17·X19/[K17·(1 + X20/K19) + X19] V18·X17·X19/[K18·(1 + X18/K16) + X19] V19·X20/[K19·(1 + X19/K17) + X20] k1 = 0.003 k2 = 0.01 k3 = V4 = 450 k5 = 0.06 k6 = k7 = 0.3 V8 = k9 =

Ngày tải lên: 13/08/2014, 16:21

... receptordouble stranded RNAsmall interference RNAnon small cell lung cancer Abstract Lung cancer has emerged as a leading cause of cancer death in the world. Non-small cell lung cancer (NSCLC) accounts ... purposes) Background Lung cancer is a leading cause of cancer death in Australia and the world [1,2]. There are two types of lung cancers, non small cell (NSCLC) and small cell (SCLC). NSCLC accounts ... effects in A549 and SPC-A1 cellsFigure 1 SiRNA-mediated RNAi effects in A549 and SPC-A1 cells. (A) dsRNA-mediated inhibition of EGFR gene expression in A549 cells (upper) and SPC-A1 cells (lower).

Ngày tải lên: 14/08/2014, 19:22

... Facts: Non-Small-Cell Lung Cancer T cell receptor Antigen T cell OFF PD-1 Tumor cell PD-L1 Tumor cell T cell ON Anti-PD-1 Anti-PD-L1 Figure 5.1 Tumor cells can present antigen to activated T cells ... PD-1 is an inhibitory cell-surface receptor that is expressed on activated T cells, B cells, natural killer cells, monocytes and dendritic cells The effector function of T cells that express PD-1 ... Villejuif, France In general, non-small-cell lung cancer (NSCLC) is associated with tumor DNA damage and mutations induced by carcinogens in tobacco smoke In the mid-1990s an antibody to one of the

Ngày tải lên: 21/01/2020, 11:49

... Non-small-cell lung cancer (NSCLC), which includes adenocarcinoma, squamous cell carcinoma and large cell carcinoma, accounts for approximately 80–85% of all lung cancers Small-cell lung cancer ... NSCLC Fast Facts Fast Facts: Non-Small-Cell Lung Cancer Mary O’Brien and Benjamin Besse ISBN 978-1-910797-19-8 the best offers are on fastfacts.com 781910 797198 © 2016 Health Press Ltd www.fastfacts.com ... British Library ISBN 978-1-910797-19-8 O’Brien M (Mary) Fast Facts: Non-Small-Cell Lung Cancer/ Mary O’Brien, Benjamin Besse Cover image: colored chest X-ray showing lung cancer in frontal view

Ngày tải lên: 23/01/2020, 14:49

... (92.4, 97.7%) 94.3% (90.7, 96.8%) 95.6% (92.4, 97.7%) Sensitivity 89.1% (78.9, 95.3%) 89.1% (78.9, 95.3%) 89.1% (78.9, 95.3%) Specificity 97.7% (94.6, 99.2%) 96.0% (92.2–98.2%) 97.7% (94.6, 99.2%) ... Algorithm 21 LCDT1 Algorithm SE (95% CI) 92.8% (87.9, 96.1%) 97.4% (92.0, 99.5%) 92.4% (89.2, 94.3%) SP (95% CI) 97.2% (95.5, 98.8%) 98.3% (95.4, 99.5%) 96.9% (95.2, 98.0%) The LCDT1 algorithm was ... Predictive Value (PPV) 92.5% (83.0, 97.4%) 87.5% (77.0, 94.2%) 92.5% (83.0, 97.4%) Negative Predictive Value (NPV) 96.6% (93.1, 98.6%) 96.5% (93.0, 98.5%) 96.6% (93.1, 98.6%) NSCLC Prevalence

Ngày tải lên: 17/06/2020, 03:04

... Mean lung dose (cGy) 0.747 c V20 of the both lungs (%) c 0.859 0.268 0.113 0.809 0.797 1591 (900–1891) 1550 (970–2004) 0.657 1576 (957–2100) 1588 (969–1895) 0.531 0.908 26 (20–32) 27 (13–35) 0.292 ... number: NCT01494558 (Registered 19 December 2011) Keywords: Locally advanced, Non-small-cell lung cancer, ECOG 2, Chemoradiotherapy, Efficacy, Toxicity Background Non-small-cell lung cancer (NSCLC) ... with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 1999;17(9):2692–9 Nawrocki S, Krzakowski M, Wasilewska-Tesluk E, Kowalski D, Rucinska

Ngày tải lên: 17/06/2020, 11:38

... chemotherapy for PD-L1-positive non-small-cell lung Cancer N Engl J Med 2016;375(19):1823–33 Remon J, Vilarino N, Reguart N Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): approaches ... BMC Cancer 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 (2019) 19:1074 advanced nonsquamous non–small-cell lung Cancer N Engl J Med 2015;373(17):1627–39 Hellmann MD, Rizvi NA, Goldman JW, Gettinger ... BMC Cancer (2019) 19:1074 https://doi.org/10.1186/s12885-019-6205-0 STUDY PROTOCOL Open Access Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung

Ngày tải lên: 17/06/2020, 18:37

... eradicates cancer stem cells (CSCs) and significantly reverses chemoresistance in resistant cancer cell lines [9–11, 13] Its cytotoxicity in cancer cells is copper dependent [8, 9, 19] Although ... anticancer activity of DS and DDC In contrast, modification of the ethyl groups had no significant effect on their anticancer activity Methods Cell line and reagents The non-small cell lung cancer ... High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth Clin Cancer Res 2009;15:6070–8 Liu

Ngày tải lên: 03/07/2020, 01:05

... the most common tumor type [1] Small cell lung cancer (SCLC) accounts for approximately 15% of new cases of annually diagnosed lung cancer, and up to 25% of lung cancer deaths each year [2] Approximately ... platinum easier Keywords: Small cell lung cancer, Extensive-staged, Irinotecan, Etoposide, Meta-analysis Background Lung cancer, which represents 13% of newly diagnosed cancers worldwide, is the ... databases were used to perform an electronic search by combining following words: “small cell lung cancer” or “small cell lung carcinoma,” “irinotecan” or “CPT-11,” and “etoposide” or “VP-16” To limit

Ngày tải lên: 03/07/2020, 01:36

... distinct from those of human IL-6 J Virol 1999;73(10):8268–78 33 Kim EJ, Juhnn YS Cyclic AMP signaling reduces sirtuin expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal ... Thissen JB, Antonia S Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung Br J Cancer 2016; 115(4):497–504 Hasegawa Y, Ando M, Kubo A, Isa S, Yamamoto S, Tsujino ... patients with lung and head and neck squamous cell carcinomas Cancer 2014;120(12):1898–907 24 Chen BS, Li CW Constructing an integrated genetic and epigenetic cellular network for whole cellular mechanism

Ngày tải lên: 03/07/2020, 01:48

... proliferation of A549 and H1993 cells whether followed by X-ray irradiation or not The combined treatment of MβCD and radiation resulted in additive increases in apoptosis of A549 and H1993 cells In this ... supra-additive effect on the apoptosis of A549 and H1993 cells Notably, pretreatment with mM MβCD alone produced little apoptosis in both A549 and H1993 cells (Fig 3) Increasing the concentration ... in A549 cells or at h in H1993 cells with respect to an additive effect on apoptosis (at 4, and 24 h in A549 cells: P = 0.1124, P = 0.0650, P = 0.1110; at h in H1993 cells: P = 0.7438; respectively;

Ngày tải lên: 24/07/2020, 01:11

... al BMC Cancer (2018) 18:683 https://doi.org/10.1186/s12885-018-4608-y RESEARCH ARTICLE Open Access The effect of low insurance reimbursement on quality of care for non-small cell lung cancer ... nature of this relationship, however, has not been reliably described in the field of non-small cell lung cancer (NSCLC) The objective of the current study was to examine the impact of low reimbursement ... finally improving quality of care of NSCLC Keywords: Insurance reimbursement rate, Non-small cell lung cancer, Quality indicators, Diagnosis, treatment, and outcomes Background Insurance is a

Ngày tải lên: 24/07/2020, 01:47

... Keywords: Non-small-cell lung cancer, Elderly, Cancer cachexia, Activity of daily living, Length of hospital stay, Medical cost Background The number of elderly people living with advanced lung cancer ... cancer treatments [1] In Japan, 65% of lung cancer morbidity cases and 73% of lung cancer-related deaths were attributed to elderly individuals aged ≥70 years in 2012 [2] Patients with lung cancer, ... activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study Tateaki Naito1* , Taro Okayama2,

Ngày tải lên: 06/08/2020, 03:21